跳至主要内容
临床试验/NCT02502565
NCT02502565Unknown不适用

Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia: Redefining Early Urate Disease

Washington D.C. Veterans Affairs Medical Center2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
2
主要终点
Number of Urate Depositions Detected in Ultrasound

研究概览

简要总结

An observational study to evaluate the prevalence of US changes of gout in the joints and tendons of patients with different degrees of asymptomatic hyperuricemia. The investigators' findings may support the extension of the spectrum of urate disease, and define a subset of patients that may benefit from early urate-lowering therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have at least one serum uric acid level l ≥ 7.0 mg/dL within the last two years without a clinical diagnosis of gout per American College of Rheumatology criteria30 (appendix A).
  • Patients, of matched gender and age, with normal uric acid levels will serve as controls.

排除标准

  • Patients who meet or have met the ACR criteria for Gout, unable to read English, and/or have terminal illness will not be eligible to participate in the study.
  • Patients with a diagnosis of skin psoriasis31, rheumatoid arthritis, or spondyloarthropathies will not be eligible to participate.
  • Patients who are on urate-lowering therapy.
  • Patients with 1 or 2 total knee replacements.

结局指标

主要结局

Number of Urate Depositions Detected in Ultrasound

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Washington D.C. Veterans Affairs Medical Center
申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验